Detalles de la búsqueda
1.
Association between skin barrier development and early-onset atopic dermatitis: A longitudinal birth cohort study.
J Allergy Clin Immunol;
153(3): 732-741.e8, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-37926123
2.
Clinically Meaningful Responses to Dupilumab Among Children Aged 6 Months to 5 Years with Moderate-to-severe Atopic Dermatitis who did Not Achieve Clear or Almost Clear Skin According to the Investigator's Global Assessment: A Post Hoc Analysis of a Phase 3 Trial.
Acta Derm Venereol;
104: adv13467, 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38348724
3.
Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet;
400(10356): 908-919, 2022 09 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36116481
4.
Emollients for prevention of atopic dermatitis: 5-year findings from the BEEP randomized trial.
Allergy;
78(4): 995-1006, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36263451
5.
Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial.
Br J Dermatol;
189(5): 531-539, 2023 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37463508
6.
Efficacy and safety of ciclosporin versus methotrexate in the treatment of severe atopic dermatitis in children and young people (TREAT): a multicentre parallel group assessor-blinded clinical trial.
Br J Dermatol;
189(6): 674-684, 2023 11 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37722926
7.
Characterisation of skin barrier defects in atopic dermatitis patients using Infrared Spectroscopy.
Clin Exp Dermatol;
2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38011533
8.
Early improvements in signs and symptoms predict clinical response to baricitinib in patients with moderate-to-severe atopic dermatitis.
Clin Exp Dermatol;
48(8): 881-888, 2023 Jul 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-37032446
9.
A real-world retrospective observational study exploring NHS resource use in England for the management of moderate-to-severe atopic dermatitis in secondary care for children and adolescents.
Pediatr Dermatol;
40(1): 50-63, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36127813
10.
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper.
Allergy;
77(6): 1736-1750, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34741557
11.
Enhancement of stratum corneum lipid structure improves skin barrier function and protects against irritation in adults with dry, eczema-prone skin.
Br J Dermatol;
186(5): 875-886, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34921679
12.
Different types of emollient cream exhibit diverse physiological effects on the skin barrier in adults with atopic dermatitis.
Clin Exp Dermatol;
47(6): 1154-1164, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35167133
13.
Infections in children and adolescents treated with dupilumab in pediatric clinical trials for atopic dermatitis-A pooled analysis of trial data.
Pediatr Dermatol;
39(2): 187-196, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35083774
14.
Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial.
Lancet;
395(10228): 962-972, 2020 03 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32087126
15.
The effect of water hardness on atopic eczema, skin barrier function: A systematic review, meta-analysis.
Clin Exp Allergy;
51(3): 430-451, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33259122
16.
Efficacy and safety of crisaborole in patients with mild-to-moderate atopic dermatitis and other atopic comorbidities.
Allergy Asthma Proc;
42(5): 425-431, 2021 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34474712
17.
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
J Am Acad Dermatol;
83(5): 1282-1293, 2020 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-32574587
18.
Diaper dermatitis prevalence and severity: Global perspective on the impact of caregiver behavior.
Pediatr Dermatol;
37(1): 130-136, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793090
19.
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis.
N Engl J Med;
375(24): 2335-2348, 2016 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27690741
20.
Dupilumab improves patient-reported symptoms and health-related quality of life in children aged 6-11â years with severe atopic dermatitis.
Br J Dermatol;
189(2): 238-240, 2023 07 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37120724